Nonstandard antibodies as prognostic markers in autoimmune hepatitis

被引:45
作者
Czaja, AJ
Shums, Z
Norman, GL
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] INOVA Diagnost, San Diego, CA USA
关键词
predictive indices; treatment outcome; serology; antibodies;
D O I
10.1080/08916930410001702469
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background : Antibodies to actin, chromatin, soluble liver antigen/liver pancreas and liver cytosol type 1 have been ascribed prognostic value in autoimmune hepatitis. Aim : Evaluate the performance parameters of these nonstandard autoantibodies and determine the critical battery for clinical application. Methods : All antibodies were tested concurrently by enzyme immunoassay in 106 patients who had reached a treatment outcome. Tests were repeated in 149 serum samples obtained later to assess durability of the findings. Results : Antibodies to chromatin and soluble liver antigen/liver pancreas were superior to the other markers in predicting relapse. Patients with antibodies to chromatin and/or soluble liver antigen/liver pancreas relapsed more frequently than patients without these markers (100 versus 79%, p <0.0003 ). Maximum sensitivity and predictability for relapse required combined testing, and they were 54 and 60%, respectively. Antibody status remained stable in 60% of patients during 127+/-9 months of follow-up, and antibodies to soluble liver antigen/liver pancreas were less labile than antibodies to chromatin (frequency of status change, 4 versus 22%). None of the antibodies were associated with treatment failure, death from hepatic failure or requirement for liver transplantation. Conclusions : Antibodies to chromatin and soluble liver antigen/liver pancreas are associated with relapse after corticosteroid withdrawal, and they may be useful prognostic markers. Combined testing improves but does not eliminate deficiencies in sensitivity, predictability and durability.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 35 条
[1]   CHARACTERIZATION OF THE LIVER CYTOSOL ANTIGEN TYPE-1 REACTING WITH AUTOANTIBODIES IN CHRONIC ACTIVE HEPATITIS [J].
ABUAF, N ;
JOHANET, C ;
CHRETIEN, P ;
MARTINI, E ;
SOULIER, E ;
LAPERCHE, S ;
HOMBERG, JC .
HEPATOLOGY, 1992, 16 (04) :892-898
[2]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[3]   The role of nucleosomes in lupus [J].
Amoura, Z ;
Koutouzov, S ;
Piette, JG .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (05) :369-373
[4]   Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics [J].
Baeres, M ;
Herkel, J ;
Czaja, AJ ;
Wies, I ;
Kanzler, S ;
Cancado, ELR ;
Porta, G ;
Nishioka, M ;
Simon, T ;
Daehnrich, C ;
Schlumberger, W ;
Galle, PR ;
Lohse, AW .
GUT, 2002, 51 (02) :259-264
[5]   Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis [J].
Costa, M ;
Rodríguez-Sánchez, JL ;
Czaja, AJ ;
Gelpí, C .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :364-374
[6]  
Czaja AJ, 1997, HEPATOLOGY, V25, P317
[7]  
Czaja AJ, 1996, HEPATOLOGY, V24, P1068
[8]   Behavior and significance of autoantibodies in type 1 autoimmune hepatitis [J].
Czaja, AJ .
JOURNAL OF HEPATOLOGY, 1999, 30 (03) :394-401
[9]   SIGNIFICANCE OF HLA DR4 IN TYPE-1 AUTOIMMUNE HEPATITIS [J].
CZAJA, AJ ;
CARPENTER, HA ;
SANTRACH, PJ ;
MOORE, SB .
GASTROENTEROLOGY, 1993, 105 (05) :1502-1507
[10]   Diagnosis and treatment of autoimmune hepatitis [J].
Czaja, AJ ;
Freesel, DK .
HEPATOLOGY, 2002, 36 (02) :479-497